Sign in
4

Changes in Ownership

ALNYLAM PHARMACEUTICALS, INC. Filed Acc 0001735276-20-000109

Director sold 15,000 shares at $140.00 ($2,100,000)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PAUL STEVEN M · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-18 Exercise or conversion : show line 1 in the form +15,000 $9.30 $139,500 16,000 D
2020-12-18 Sale : show line 2 in the form −15,000 $140.00 $2,100,000 1,000 D
Open-market sales · 15,000 sh · avg $140.00 · $2,100,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-12-18 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −15,000 $9.30 2021-06-09 15,000 0 D
Loading xslF345X03/edgardoc.xml…